Healthcare organizations are drowning in successful AI pilots that never become operational reality. A new report from Qventus surveying more than 60 chief information officers (CIOs), Chief AI Officers, and senior IT leaders at medium and large U.S. health systems reveals a troubling disconnect: while 65% of leaders rate the pressure to operationalize AI at 7 or higher on a 10-point scale, only 4% have actually achieved scaled implementation with measurable outcomes .

The stakes are enormous. Ninety-four percent of respondents said delays in operationalizing AI would put their organization at a competitive disadvantage, and 77% reported that even a one-to-two year delay would result in meaningful lost savings and efficiency gains . Yet the path from promising proof-of-concept to enterprise-wide deployment remains murky for most health systems.

What's Actually Blocking Healthcare AI from Scaling?

The barriers to scaling AI in healthcare are surprisingly concrete and measurable. Seventy-four percent of leaders cite dependency on electronic health records (EHR) systems as a top execution barrier. This dependency has shifted dramatically in just one year: willingness to wait for an EHR vendor to build AI features dropped from 52% in 2025 to just 22% in 2026 . Health systems are losing patience with the traditional vendor ecosystem.

Beyond EHR challenges, the operational complexity of scaling AI pilots reveals deeper structural problems:

• Scaling Difficulty: Forty-five percent cite difficulty scaling pilots as a top obstacle, with only 4% having achieved scaled implementation with measurable outcomes across their organization.
• Vendor Management Burden: Fifty-one percent report spending 11% to 25% of IT bandwidth on vendor management, integrations, and implementations alone, diverting resources from actual AI deployment.
• ROI Measurement Gaps: A significant portion of health systems struggle to assess whether their AI investments are actually delivering financial returns, making it difficult to justify continued spending.

The irony is sharp: the explosion of AI capability has made the problem worse, not better. Agentic AI, which refers to AI systems that can take autonomous actions without constant human direction, has made it exponentially easier to build AI solutions in controlled environments. But that same explosion of capability has made operationalizing those solutions ten times harder in real-world hospital operations .

"The pace of change in the past year has been remarkable. Agentic AI has made it exponentially easier to build solutions, but that same explosion of capability has made operationalizing AI ten times harder," said Mudit Garg, co-founder and CEO of Qventus.

Mudit Garg, Co-founder and CEO, Qventus

How Can Health Systems Close the Pilot-to-Payoff Gap?

The research identifies specific strategies that separate health systems driving enterprise-wide impact from those stuck in pilot purgatory. CIOs and technology leaders should focus on these critical moves:

• Consolidate Vendors: Instead of adopting multiple point solutions that each require separate integrations and management, health systems should consolidate around fewer, more comprehensive AI partners that can address multiple operational challenges simultaneously.
• Align Risk and Reward: Establish shared risk and reward structures with vendors, ensuring that AI vendors have skin in the game and are motivated to deliver sustained ROI rather than just successful pilots.
• Treat AI as Core Infrastructure: Move AI from a special project or innovation initiative to a core component of the technology stack, with dedicated governance, funding, and accountability structures.
• Prioritize Operational Readiness: Before scaling, ensure that the underlying operational processes, data quality, and staff training are ready to support autonomous or semi-autonomous AI workflows.

The good news is that some health systems are already running AI workflows with limited staff oversight. Fifty-five percent of respondents report operating AI systems that require minimal human intervention, laying the groundwork for more autonomous operations . This suggests that the technical foundation for scaling is possible; the barrier is organizational and strategic, not technological.

"The decisions we're making about AI right now are among the most consequential we've faced, and the margin for error is razor thin," said Jim Whitfill, Senior Vice President of Strategic Partnerships and Chief Transformation Officer at HonorHealth.

Jim Whitfill, SVP Strategic Partnerships and Chief Transformation Officer, HonorHealth

Why Does This Matter Beyond Healthcare?

The healthcare AI scaling crisis mirrors a broader enterprise challenge. Across industries, organizations are discovering that the ability to build AI pilots is not the same as the ability to deploy them at scale. The Qventus report focuses on healthcare, but the underlying dynamics reflect a universal problem: CIOs and technology leaders are now the primary decision makers on AI purchasing, with nearly 45% of health system CIOs holding this responsibility . That responsibility comes with enormous pressure to deliver measurable business value, not just technical capability.

Meanwhile, research from International Data Corporation (IDC) suggests that the broader AI economy is entering an inflection point. IDC forecasts that AI will generate $22.5 trillion in cumulative global economic value by 2031, driven by productivity gains, new revenue models, and business transformation . However, IDC emphasizes that this value depends critically on how quickly organizations move from experimentation to operational deployment. As Meredith Whalen, Chief Product and Research Officer at IDC, noted, "The next phase of the AI market will be defined by execution. The opportunity is clear, but execution is now the constraint" .

Meredith Whalen, Chief Product and Research Officer at IDC

For health systems facing razor-thin margins, a worsening workforce crisis, and spending cuts to Medicaid and the Affordable Care Act over the next decade, the ability to operationalize AI is not optional. It is a competitive necessity. The question is no longer whether to invest in AI, but how to move from pilots to payoff before competitors do.